Black Swan Sale

50% Off Elite

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

EXAS

Exact Sciences Corp

Nov 24 • 04:00PM ET

101.01

+0.11 0.11 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN GH NTRA TXG DGX FLGT BIO QDEL MYGN CSTM

| Held by: VTI VB XBI VBK VXF IWR FBT SCHM CGGR IWD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.32	Insider Own	1.62%	Shs Outstand	189.45M	Perf Week	50.42%
Market Cap	19.14B	Forward P/E	330.58	EPS next Y	0.31	Insider Trans	-0.99%	Shs Float	186.40M	Perf Month	56.27%
Enterprise Value	20.67B	PEG	-	EPS next Q	-0.10	Inst Own	94.63%	Short Float	4.26%	Perf Quarter	119.06%
Income	-986.58M	P/S	6.21	EPS this Y	87.43%	Inst Trans	-1.54%	Short Ratio	1.92	Perf Half Y	78.59%
Sales	3.08B	P/B	7.65	EPS next Y	143.50%	ROA	-15.60%	Short Interest	7.94M	Perf YTD	79.77%
Book/sh	13.20	P/C	19.08	EPS next 5Y	-	ROE	-34.54%	52W High	101.87 -0.84%	Perf Year	91.67%
Cash/sh	5.29	P/FCF	77.46	EPS past 3/5Y	-17.13% -54.24%	ROIC	-19.74%	52W Low	38.81 160.26%	Perf 3Y	134.85%
Dividend Est.	-	EV/EBITDA	211.79	Sales past 3/5Y	16.01% 25.78%	Gross Margin	69.42%	Volatility	7.55% 4.44%	Perf 5Y	-12.65%
Dividend TTM	-	EV/Sales	6.71	EPS Y/Y TTM	-353.69%	Oper. Margin	-3.92%	ATR (14)	3.86	Perf 10Y	967.76%
Dividend Ex-Date	-	Quick Ratio	2.44	Sales Y/Y TTM	14.47%	Profit Margin	-32.01%	RSI (14)	91.11	Recom	2.58
Dividend Gr. 3/5Y	- -	Current Ratio	2.72	EPS Q/Q	49.98%	SMA20	38.71%	Beta	1.22	Target Price	100.31
Payout	-	Debt/Eq	1.01	Sales Q/Q	20.05%	SMA50	58.33%	Rel Volume	3.50	Prev Close	100.90
Employees	7000	LT Debt/Eq	1.00	Earnings	Nov 03 AMC	SMA200	90.46%	Avg Volume	4.14M	Price	101.01
IPO	Jan 31, 2001	Option/Short	Yes / Yes	EPS/Sales Surpr.	-63.40% 4.96%	Trades		Volume	14,479,614	Change	0.11%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-10-25	Initiated	Mizuho	Outperform	$60
Mar-13-25	Initiated	RBC Capital Mkts	Sector Perform	$52
Jan-23-25	Initiated	Barclays	Overweight	$70
Aug-28-24	Initiated	Wells Fargo	Overweight	$75
Jun-27-24	Initiated	Scotiabank	Sector Outperform	$70
Jun-03-24	Resumed	Jefferies	Buy	$75
Jan-02-24	Upgrade	The Benchmark Company	Hold → Buy	$91
Dec-14-23	Initiated	Guggenheim	Buy	$90
Dec-13-23	Initiated	Wolfe Research	Outperform	$95
Oct-10-23	Upgrade	Piper Sandler	Neutral → Overweight	$90
Sep-28-23	Initiated	Bernstein	Outperform	$83
Aug-02-23	Downgrade	The Benchmark Company	Buy → Hold
May-10-23	Upgrade	Craig Hallum	Hold → Buy	$55 → $85
May-05-23	Initiated	UBS	Neutral	$73
Mar-09-23	Upgrade	Citigroup	Neutral → Buy	$70 → $90
Feb-10-23	Downgrade	Credit Suisse	Outperform → Neutral	$50 → $70
Jan-18-23	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-19-22	Downgrade	Craig Hallum	Buy → Hold	$60 → $35
Aug-25-22	Initiated	Credit Suisse	Outperform	$55
Jun-03-22	Initiated	Piper Sandler	Neutral	$50

Show Previous Ratings

Today 01:33AM	Halper Sadeh LLC Encourages GDOT, BLFY, EXAS Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
Nov-24-25 04:35PM	Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium (Business Wire)
09:41AM	Booking, Carvana upgraded: Wall Street's top analyst calls (The Fly)
09:20AM	Here are Mondays Top Wall Street Analyst Research Calls: Baidu, Carvana, Exact Sciences, Ferrari, Marvell Technology, Meta Platforms and More (24/7 Wall St.)
Nov-23-25 10:30PM	Q3 Earnings Highs And Lows: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Immuno-Oncology Stocks (StockStory)
09:10AM	Loading…
Nov-21-25 09:10AM	Here Are Fridays Top Wall Street Analysts Research Calls: Advanced Micro Devices, Block, Broadcom, Exact Sciences, Hologic, Palo Alto Networks and More (24/7 Wall St.)
07:32AM	Health Care Roundup: Market Talk (The Wall Street Journal)
06:30AM	Abbott Breaks into Lucrative Cancer Screening Market with $21 Billion Exact Sciences Purchase (The Daily Upside)
04:50AM	Abbott to acquire all outstanding shares in Exact Sciences (Medical Device Network)
03:35AM	Stock Market Today: Dow Futures Inch Up; Bitcoin Slides; VIX Jumps (The Wall Street Journal)
Nov-20-25 07:50PM	Halper Sadeh LLC Encourages CIVI, JAMF, EXAS Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire) +16.81%
07:43PM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
06:29PM	Why the Stock Price of This Cancer Screening Company Soared 17% Thursday (Investopedia)
05:06PM	Health Care Roundup: Market Talk (The Wall Street Journal)
05:05PM	Stocks to Watch Thursday Recap: Walmart, Nvidia, Cracker Barrel, Regeneron (The Wall Street Journal)
04:44PM	Loading…
04:44PM	Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More (Motley Fool)
04:23PM	These Stocks Moved the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Alphabet, Palo Alto Networks, and More (Barrons.com)
04:15PM	Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth (Business Wire)
04:14PM	Exact Sciences Catapults On $23 Billion Abbott Labs Buyout (Investor's Business Daily)
03:31PM	Why Exact Sciences Rallied Over 50% This Week (Motley Fool)
03:08PM	Abbott Laboratories announces $21 billion deal to buy Cologuard-maker Exact Sciences (Chicago Tribune)
03:03PM	Exact Sciences Stock Pops on $21 Billion Deal. Is It Too Late to Buy EXAS Here? (Barchart)
03:01PM	Why Exact Sciences Stock Surged Today (Motley Fool)
02:47PM	These Stocks Are Moving the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Alphabet, Palo Alto Networks, and More (Barrons.com)
01:36PM	Stocks to Watch Thursday: Walmart, Nvidia, Cracker Barrel, Regeneron (The Wall Street Journal)
01:02PM	Top Stock Movers Now: Walmart, Nvidia, Exact Sciences, Bath and Body Works, and More (Investopedia)
12:01PM	Madison's Exact Sciences' $23 billion sale is tied to its Cologuard cancer test. What to know (Milwaukee Journal Sentinel)
11:51AM	Abbott Laboratories Will Buy Cologuard Maker Exact Sciences for $21 Billion (Barrons.com)
11:32AM	What to know about Exact Sciences. The Madison company was sold to Abbot for $23 billion. (Milwaukee Journal Sentinel)
10:21AM	Exact Sciences Soars As Abbott Unveils $21 Billion Buyout (GuruFocus.com)
09:41AM	Loading…
09:41AM	Stocks to Watch Thursday: Walmart, Nvidia, Exact Sciences (The Wall Street Journal)
09:31AM	Abbott strikes $23bn deal for Cologuard cancer test maker Exact Sciences (Financial Times)
09:26AM	Abbott to buy Exact Sciences for $21B, Verizon to cut 13K jobs (Yahoo Finance Video)
08:43AM	Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test (MarketWatch)
08:09AM	Exact Sciences stock jumps after Abbott confirms acquisition (Investing.com)
07:46AM	Exact Sciences Stock Soars. Abbott Is Buying It in Deal Valued at $21 Billion. (Barrons.com)
07:46AM	Abbott to Acquire Exact Sciences for $21 Billion (The Wall Street Journal)
07:30AM	Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments (PR Newswire)
06:27AM	Exact Sciences (EXAS) Climbs to 2-Year High on Abbot Merger Reports (Insider Monkey)
Nov-19-25 07:21PM	Why Exact Sciences Stock Blasted Nearly 24% Higher Today (Motley Fool) +23.68%
04:57PM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
04:31PM	Exact Sciences Catapults, Breaking Out, On Rumored Abbott Laboratories Buyout (Investor's Business Daily)
04:27PM	Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories (Barrons.com)
02:36PM	Exact Sciences shares soar on report Abbott is nearing deal for the company (Investing.com)
11:19AM	Stock Market Today: Fed Minutes Weigh on U.S. Equities As Traders Await News (TheStreet)
06:22AM	Freenome and Roche partner on cancer screening technology for ex-US markets (Medical Device Network)
Nov-17-25 01:13PM	Molina Secures Deal From AHCA to Serve Florida's Medicaid Members (Zacks)
Nov-15-25 09:00AM	Alphabets Secret Portfolio Just Bought These 2 Stocks. Should You Buy Too? (24/7 Wall St.)
Nov-14-25 07:57AM	TEM Continues to Strengthen Its Genomics Leadership With New Products (Zacks)
Nov-13-25 11:07AM	Ensign Group Shares Decline 2.2% Despite Q3 Earnings Beat (Zacks)
Nov-12-25 09:33AM	RGTI Stock Down Despite Q3 Earnings Top Estimates, Revenues Decline Y/Y (Zacks)
07:02AM	Cathie Wood doubles down on Alibaba: ARK Invest snaps up $25M in Chinese tech stocks (GuruFocus.com)
Nov-11-25 12:24PM	Encompass Health Shares Down 8% Despite Q3 Earnings & Revenue Beat (Zacks)
Nov-10-25 12:55PM	Tenet Healthcare Shares Down 5% Despite Q3 Earnings Beat (Zacks)
09:40AM	Is Exact Sciences (EXAS) Stock Outpacing Its Medical Peers This Year? (Zacks)
07:00AM	Exact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome's Blood-Based Colorectal Cancer Screening Tests (Business Wire)
12:31AM	The 5 Most Interesting Analyst Questions From Exact Sciences's Q3 Earnings Call (StockStory)
Nov-08-25 10:45AM	2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term (Motley Fool)
Nov-07-25 12:46PM	AMN Stock Gains Following Q3 Earnings & Revenue Beat, Margins Down (Zacks)
12:41PM	Doximity Stock Down Despite Q2 Earnings Beat, Revenues Up Y/Y (Zacks)
08:00AM	Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test (Business Wire)
Nov-06-25 01:25PM	QuidelOrtho Q3 Earnings and Revenues Beat Estimates, Margins Expand (Zacks)
01:22PM	Inogen Stock Dips Despite Q3 Earnings Beat, Revenues Up Y/Y (Zacks)
01:19PM	PACB Stock Down Despite Q3 Earnings Beat Estimates, Revenues Down Y/Y (Zacks)
01:00PM	CONMED Q3 Earnings and Revenues Beat Estimates, Margins Contract (Zacks)
12:58PM	BD Stock Slips in Pre-Market Despite Q4 Earnings Beat, Margins Up (Zacks)
Nov-05-25 12:20PM	Earnings Estimates Rising for Exact Sciences (EXAS): Will It Gain? (Zacks)
12:12PM	Hims & Hers Stock Slips Post Y/Y Q3 Earnings Decline, Margins Contract (Zacks)
12:09PM	MASI Stock Gains Post Q3 Earnings and Revenue Beat, Margins Expand (Zacks)
10:08AM	Amicus' Q3 Earnings Beat, Higher Product Sales Drive Y/Y Revenues (Zacks)
09:45AM	Here's Why Exact Sciences (EXAS) is a Strong Growth Stock (Zacks)
06:26AM	Exact Sciences Raises Outlook After Record-Breaking Quarter (GuruFocus.com)
Nov-04-25 08:05PM	Why Exact Sciences Stock Blasted Higher on Tuesday (Motley Fool)
07:20PM	Exact Sciences (EXAS) is an Intriguing Medical Stock to Watch After Q3 Earnings (Zacks)
10:32AM	Why Exact Sciences' Report Should 'Allay Fears Of A Market Slowdown' (Investor's Business Daily)
08:40AM	EXAS Q3 Deep Dive: Cologuard Plus, Care Gap Programs, and New Test Launches Drive Growth (StockStory)
08:38AM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
07:00AM	Exact Sciences to Participate in November Investor Conference (Business Wire)
12:04AM	Exact Sciences Corp (EXAS) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
Nov-03-25 06:05PM	Exact Sciences (EXAS) Q3 Earnings and Revenues Beat Estimates (Zacks)
05:04PM	Exact Sciences: Q3 Earnings Snapshot (Associated Press Finance)
05:00PM	Exact Sciences (NASDAQ:EXAS) Reports Upbeat Q3, Stock Soars (StockStory)
04:29PM	Exact Sciences Flirts With A Breakout On Guidance Hike, Sales Beat (Investor's Business Daily)
04:05PM	Exact Sciences Announces Third Quarter 2025 Results (Business Wire)
Nov-02-25 06:53AM	Should You Buy Exact Sciences Stock Before Nov. 3? (Motley Fool)
Nov-01-25 11:07PM	Exact Sciences (EXAS) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-31-25 01:53PM	Rigel Gears Up to Report Q3 Earnings: Here's What to Expect (Zacks)
01:52PM	Coupang Set to Report Q3 Earnings: What's in Store for the Stock? (Zacks)
09:15AM	Arcutis Biotherapeutics, Inc. (ARQT) Hits Fresh High: Is There Still Room to Run? (Zacks)
Oct-29-25 01:47PM	Zoetis Gears Up to Report Q3 Earnings: Here's What to Expect (Zacks)
08:57AM	TEM vs. EXAS: Which Genomics Player Offers Greater Upside? (Zacks)
Oct-28-25 11:52AM	Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards? (Zacks)
10:00AM	Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
09:17AM	Avidity Biosciences (RNA) Moves 42.4% Higher: Will This Strength Last? (Zacks)
Oct-27-25 12:44PM	ANI Pharmaceuticals to Report Q3 Earnings: Is a Beat in the Cards? (Zacks)
10:00AM	Exact Sciences (EXAS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
07:00AM	Exact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps Improve Adherence and Close Screening Gaps (Business Wire)
Oct-24-25 09:57AM	Incyte Gears Up to Report Q3 Earnings: Is a Beat in the Cards? (Zacks)
08:53AM	Here's How Charles River Stock Is Placed Ahead of Q3 Earnings (Zacks)

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ORVILLE JACOB A	EVP, GM, Screening	Nov 19 '25	Sale	75.00	5,000	375,000	23,237	Nov 21 05:30 PM
Herriott James	SVP, General Counsel & Sec	Nov 19 '25	Sale	70.00	1,000	70,000	11,585	Nov 21 05:30 PM
ORVILLE JACOB A	Officer	Nov 19 '25	Proposed Sale	75.00	5,000	375,000		Nov 19 03:11 PM
Herriott James	Officer	Nov 19 '25	Proposed Sale	70.00	1,000	70,000		Nov 19 12:04 PM
Herriott James	SVP, General Counsel & Sec	Nov 04 '25	Sale	70.08	1,500	105,120	12,585	Nov 06 05:29 PM
Baranick Brian	EVP, GM, Precision Oncology	Nov 04 '25	Sale	70.08	2,858	200,289	22,368	Nov 06 05:29 PM
Baranick Brian	Officer	Nov 04 '25	Proposed Sale	70.08	2,858	200,289		Nov 04 10:25 AM
Herriott James	Officer	Nov 04 '25	Proposed Sale	70.08	1,500	105,120		Nov 04 10:22 AM
Zanotti Katherine S	Director	Oct 24 '25	Sale	65.00	12,000	780,000	60,759	Oct 27 08:35 PM
Zanotti Katherine S	Director	Oct 24 '25	Proposed Sale	65.00	12,000	780,000		Oct 24 11:08 AM
Herriott James	SVP, General Counsel & Sec	Oct 09 '25	Sale	60.00	1,500	90,000	14,085	Oct 10 05:27 PM
Doyle James Edward	Director	Oct 09 '25	Sale	60.00	2,000	120,000	57,962	Oct 10 05:25 PM
Herriott James	Officer	Oct 09 '25	Proposed Sale	60.00	1,500	90,000		Oct 09 11:23 AM
Doyle James Edward	Director	Oct 09 '25	Proposed Sale	60.00	2,000	120,000		Oct 09 11:18 AM
Doyle James Edward	Director	Aug 13 '25	Sale	42.02	1,485	62,400	59,962	Aug 14 04:30 PM
Doyle James Edward	Director	Aug 13 '25	Proposed Sale	42.02	1,485	62,400		Aug 13 10:09 AM
ORVILLE JACOB A	EVP, GM, Screening	Aug 05 '25	Option Exercise	0.00	5,350	0	30,752	Aug 07 05:30 PM
Baranick Brian	EVP, GM, Precision Oncology	Aug 05 '25	Option Exercise	0.00	5,350	0	27,943	Aug 07 05:30 PM
Sebelius Kathleen	Former Director	Jul 16 '25	Proposed Sale	53.11	8,164	433,605		Jul 16 04:22 PM
Zanotti Katherine S	Director	Jun 13 '25	Sale	53.20	3,207	170,612	72,759	Jun 16 05:30 PM
Zanotti Katherine S	Director	Jun 13 '25	Proposed Sale	53.20	3,207	170,612		Jun 13 09:50 AM
Bloomer Aaron	EVP, Chief Financial Officer	Apr 15 '25	Option Exercise	0.00	24,460	0	19,340	Apr 17 04:30 PM
Conroy Kevin T	President and CEO	Mar 07 '25	Option Exercise	22.38	66,723	1,493,261	1,203,269	Mar 10 05:00 PM
Herriott James	SVP, General Counsel & Sec	Feb 28 '25	Option Exercise	0.00	4,265	0	16,339	Mar 04 04:48 PM
Conroy Kevin T	President and CEO	Feb 28 '25	Option Exercise	0.00	40,310	0	1,146,965	Mar 04 04:47 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 28 '25	Option Exercise	0.00	9,673	0	25,106	Mar 04 04:44 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 28 '25	Option Exercise	0.00	9,673	0	27,728	Mar 04 04:40 PM
Condella Sarah	EVP, Human Resources	Feb 28 '25	Option Exercise	0.00	7,738	0	84,399	Mar 04 04:37 PM
Condella Sarah	EVP, Human Resources	Feb 25 '25	Option Exercise	0.00	3,954	0	80,297	Feb 26 08:00 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 25 '25	Option Exercise	0.00	3,954	0	19,841	Feb 26 08:00 PM
Herriott James	SVP, General Counsel & Sec	Feb 25 '25	Option Exercise	0.00	1,647	0	13,738	Feb 26 08:00 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 25 '25	Option Exercise	0.00	3,954	0	22,136	Feb 26 08:00 PM
Conroy Kevin T	President and CEO	Feb 25 '25	Option Exercise	0.00	13,180	0	1,121,378	Feb 26 08:00 PM
Conroy Kevin T	President and CEO	Feb 19 '25	Option Exercise	0.00	10,374	0	1,084,565	Feb 21 04:30 PM
COWARD D SCOTT	Director	Feb 19 '25	Option Exercise	0.00	2,248	0	52,831	Feb 21 04:30 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 19 '25	Option Exercise	0.00	2,248	0	16,688	Feb 21 04:30 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 19 '25	Option Exercise	0.00	1,729	0	14,487	Feb 21 04:30 PM
Condella Sarah	EVP, Human Resources	Feb 19 '25	Option Exercise	0.00	2,248	0	74,859	Feb 21 04:30 PM
Herriott James	SVP, General Counsel & Sec	Feb 19 '25	Option Exercise	0.00	865	0	10,731	Feb 21 04:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Black Swan Sale

50% Off Elite

EXAS

Exact Sciences Corp

Upgrade your FINVIZ experience